FBB
BSX icon

Fulton Breakefield Broenniman’s Boston Scientific BSX Stock Holding History

Fulton Breakefield Broenniman’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Buy
+3,603
New +$288K 0.01% 183
2020
Q2 		– Sell
-6,805
Closed -$222K – 166
2020
Q1 		$222K Sell
6,805
-3,990
-37% -$156K 0.03% 142
2019
Q4 		$488K Buy
10,795
+1,745
+19% +$73K 0.06% 118
2019
Q3 		$368K Buy
+9,050
New +$383K 0.05% 125

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fulton Breakefield Broenniman's BSX Position: Q1 2026 in Review

Fulton Breakefield Broenniman opened a new position in Boston Scientific (BSX) in Q1 2026: 3,603 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #183 among its holdings. This is a return to the name: Fulton Breakefield Broenniman previously reported a position in BSX as recently as Q1 2020.

Fulton Breakefield Broenniman first reported a position in BSX in Q3 2019 and has held it in 4 quarters since. The position peaked at $488K in Q4 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Fulton Breakefield Broenniman held 3,603 shares of Boston Scientific worth $226K as of Q1 2026.
  • Boston Scientific was a new Fulton Breakefield Broenniman position in Q1 2026.
  • Boston Scientific made up 0.01% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #183 holding.
  • Fulton Breakefield Broenniman first reported a position in Boston Scientific in Q3 2019 and has held it in 4 quarters since.
  • Fulton Breakefield Broenniman's Boston Scientific position peaked at $488K in Q4 2019.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.